I wish I was making this up.
After the bell yesterday, Provention Bio (PRVB) announced a Financing.
It’s like a bad dream. All over again.
You’ll recall, on the heels of the ADA meeting last year, when the company also announced groundbreaking data, management attempted a financing, which they ultimately yanked.
Back then, I didn’t mince words.
“Management are idiots for not letting the momentum and groundswell of media interest crescendo before printing a deal, say north of $20 per share.” (See here for the full take).
I’m not going to mince words this time, either.
However, there is one thing I am going to do differently. To find out what, click the link below…
Want to keep reading? No problem! All you have to do is sign up for FREE here as a registered user.
By doing so, you agree to receive periodic research updates from DTR and only DTR.
We will never rent, sell or share your info.